Profitability Metrics

Gross Margin
33.38%
Operating Margin
13.24%
Net Margin
11.95%

Efficiency Metrics

Revenue per Expense Ratio
1.15
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
18.00%
Income Tax Rate
23.36%
EPS
1.2800000000

Balance Sheet Analysis

Current Ratio
3.59
Cash Ratio
1.81
Working Capital
$245.76M
Debt to Equity
0.02
Debt to Assets
1.47%
Equity Ratio
75.93%

Cash Flow Analysis

Operating Cash Flow Ratio
12.30%
Free Cash Flow Ratio
8.81%
CapEx to Revenue
3.48%
Dividends Paid
$25.08M
Stock Buybacks
$33.11M
Total Shareholder Returns
$58.19M
Cash Position Change
42.24%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 3.37%

Detailed Growth Metrics

Core Performance

Revenue
12.90%
Net Income
21.04%
EPS
23.08%
Operating Income
-8.06%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
27.08%
Operating Cash Flow
31.31%
Free Cash Flow
39.26%

Balance Sheet Health

Assets
6.44%
Debt
19.57%
Book Value per Share
6.74%
Inventory
12.64%

Shareholder Returns

Dividends per Share
3.37%
Shares Outstanding
-1.50%

Long Term Trends

3Y Revenue/Share
70.00%
5Y Revenue/Share
53.34%
3Y Dividend/Share
9.62%
5Y Dividend/Share
12.87%